European evidence-based guidelines on pancreatic cystic neoplasms
2018/03/24 by The European Study Group on Cystic Tumours of the Pancreas · 37 citations
Medicine · #Pancreatic and Hepatic Oncology Research #Pancreatitis Pathology and Treatment #Gastrointestinal disorders and treatments
paper · pdf · doi:10.1136/gutjnl-2018-316027
Abstract
Evidence-based guidelines on the management of pancreatic cystic neoplasms (PCN) are lacking. This guideline is a joint initiative of the European Study Group on Cystic Tumours of the Pancreas, United European Gastroenterology, European Pancreatic Club, European-African Hepato-Pancreato-Biliary Association, European Digestive Surgery, and the European Society of Gastrointestinal Endoscopy. It replaces the 2013 European consensus statement guidelines on PCN. European and non-European experts performed systematic reviews and used GRADE methodology to answer relevant clinical questions on nine topics (biomarkers, radiology, endoscopy, intraductal papillary mucinous neoplasm (IPMN), mucinous cystic neoplasm (MCN), serous cystic neoplasm, rare cysts, (neo)adjuvant treatment, and pathology). Recommendations include conservative management, relative and absolute indications for surgery. A conservative approach is recommended for asymptomatic MCN and IPMN measuring <40 mm without an enhancing nodule. Relative indications for surgery in IPMN include a main pancreatic duct (MPD) diameter between 5 and 9.9 mm or a cyst diameter ≥40 mm. Absolute indications for surgery in IPMN, due to the high-risk of malignant transformation, include jaundice, an enhancing mural nodule >5 mm, and MPD diameter >10 mm. Lifelong follow-up of IPMN is recommended in patients who are fit for surgery. The European evidence-based guidelines on PCN aim to improve the diagnosis and management of PCN.
Cited by
- Pancreatic cyst fluid glucose in differentiating mucinous from nonmucinous pancreatic cysts: a systematic review and meta-analysis
- Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future
- Predictors of adverse events after endoscopic ultrasound-guided through-the-needle biopsy of pancreatic cysts: a recursive partitioning analysis
- Contrast-enhanced EUS for the characterization of mural nodules within pancreatic cystic neoplasms: systematic review and meta-analysis
- An Overview for Clinicians on Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas
- Percentage of Pancreatic Cysts on MRI With a Pancreatic Carcinoma: Systematic Review and Meta‐Analysis
- Radiomics Improves Cancer Screening and Early Detection
- Mural nodules and prevalence of high-grade dysplasia in branch duct intraductal papillary mucinous neoplasm of the pancreas undergoing resection
- The exposome and pancreatic cancer, lifestyle and environmental risk factors for PDAC
- Cyst-X: A Federated AI System Outperforms Clinical Guidelines to Detect Pancreatic Cancer Precursors and Reduce Unnecessary Surgery
- Leveraging Fine-Tuned Large Language Models for Interpretable Pancreatic Cystic Lesion Feature Extraction and Risk Categorization
- Islet autotransplantation in intraductal papillary mucinous neoplasm: A “Pole Pole” (slowly, slowly) path toward careful expansion of indications
- Single-Cell Transcriptomics of Pancreatic Cancer Precursors Demonstrates Epithelial and Microenvironmental Heterogeneity as an Early Event in Neoplastic Progression. [europepmc]
- Pancreatic cancer: A review of clinical diagnosis, epidemiology, treatment and outcomes. [europepmc]
- Early Detection of Pancreatic Cancer: Opportunities and Challenges. [europepmc]
- Enrichment of oral microbiota in early cystic precursors to invasive pancreatic cancer. [europepmc]
- Usefulness of Deep Learning Analysis for the Diagnosis of Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. [europepmc]
- Liquid Biopsy Approach for Pancreatic Ductal Adenocarcinoma. [europepmc]
- A multimodality test to guide the management of patients with a pancreatic cyst. [europepmc]
- Overview and comparison of guidelines for management of pancreatic cystic neoplasms. [europepmc]
- Radiomics in stratification of pancreatic cystic lesions: Machine learning in action. [europepmc]
- Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium. [europepmc]
- Surgical strategy for intraductal papillary mucinous neoplasms of the pancreas. [europepmc]
- Early detection of pancreatic cancer. [europepmc]
- Endoscopic ultrasound (EUS) and the management of pancreatic cancer. [europepmc]
- Pancreatic cancer treatment: better, but a long way to go. [europepmc]
- Radiomics Improves Cancer Screening and Early Detection. [europepmc]
- Factors Associated With the Risk of Progression of Low-Risk Branch-Duct Intraductal Papillary Mucinous Neoplasms. [europepmc]
- Extracellular Vesicle Analysis Allows for Identification of Invasive IPMN. [europepmc]
- A Review of the Diagnosis and Management of Premalignant Pancreatic Cystic Lesions. [europepmc]
- Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery. [europepmc]
- UEG position paper on pancreatic cancer. Bringing pancreatic cancer to the 21st century: Prevent, detect, and treat the disease earlier and better. [europepmc]
- Isolation of pancreatic microbiota from cystic precursors of pancreatic cancer with intracellular growth and DNA damaging properties. [europepmc]
- Prospective, Multi-Institutional, Real-Time Next-Generation Sequencing of Pancreatic Cyst Fluid Reveals Diverse Genomic Alterations That Improve the Clinical Management of Pancreatic Cysts. [europepmc]
- Pancreatic Cancer: Changing Epidemiology and New Approaches to Risk Assessment, Early Detection, and Prevention. [europepmc]
- A Combined DNA/RNA-based Next-Generation Sequencing Platform to Improve the Classification of Pancreatic Cysts and Early Detection of Pancreatic Cancer Arising From Pancreatic Cysts. [europepmc]
- Surveillance for Presumed BD-IPMN of the Pancreas: Stability, Size, and Age Identify Targets for Discontinuation. [europepmc]
Related